Indivior logo

INDV - Indivior News Story

134p 0.8  0.6%

Last Trade - 16/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £984.4m
Enterprise Value £570.1m
Revenue £467.8m
Position in Universe 438th / 1819

Indivior PLC - Further statement re claim filed by RB

Mon 30th November, 2020 7:00am
RNS Number : 8416G
Indivior PLC
30 November 2020
 

Indivior is providing the following statement pursuant to its initial statement dated November 27, 2020, related to a claim filed against it by Reckitt Benckiser Group.

 

Indivior PLC ("Indivior" or "the Company"), as an entitled party, has reviewed the claim Reckitt Benckiser Group ("RB") filed against the Company in the Commercial High Court in London on November 13, 2020. At the present time, the claim has not been served on the Company. Indivior notes reported comments by RB, as published in The Times and Financial Times newspapers on November 27, 2020, that RB "regularly takes certain procedural steps to preserve potential claims."

 

Based on the information available to it, Indivior strongly believes that the claim is without merit and that it has strong grounds for defending against the claim should it be served. If the claim is served, Indivior will fully and vigorously defend itself in any proceedings related to the claim.

 

Indivior will make further announcements as appropriate, including in relation to whether the claim is served.

 

 

For Further Information

Investor Enquiries

 

Jason Thompson

VP, Investor Relations Indivior PLC

+1 804 402 7123

jason.thompson@indivior.com

Media Enquiries

Jonathan Sibun
 

Tulchan Communications

US Media Inquiries

 

+44 207 353 4200
 

+1 804 594 0836

Indiviormediacontacts@indivior.com

 

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURBLBMTMTITTTM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.